Reaction

Type 2 Lepra Reaction reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 186 reports · 10 co-occurring drugs

As of the last recalculation, Type 2 Lepra Reaction appears in 186 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is MINOCYCLINE (PRR 892.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Minocycline62892.2897.0
Daspone49764.0767.9
Dapsone Gel, 5%49763.7767.6
Dapsone49697.0700.2
Rifampin61695.3698.2
Rifampicin35476.6478.3
Moxifloxacin37366.7367.6
Moxifloxacin Hydrochloride37254.7255.2
Thalidomide43170.2170.4
Colchicine22105.9106.0

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.